DE602004027086D1 - Klassifizierung von kolonkrebs - Google Patents

Klassifizierung von kolonkrebs

Info

Publication number
DE602004027086D1
DE602004027086D1 DE602004027086T DE602004027086T DE602004027086D1 DE 602004027086 D1 DE602004027086 D1 DE 602004027086D1 DE 602004027086 T DE602004027086 T DE 602004027086T DE 602004027086 T DE602004027086 T DE 602004027086T DE 602004027086 D1 DE602004027086 D1 DE 602004027086D1
Authority
DE
Germany
Prior art keywords
cancer
classification
treatment
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004027086T
Other languages
English (en)
Inventor
Torben Falck Oerntoft
Jens Ledet Jensen
Mogens Kruhoeffer
Paeivi Laiho
Lauri A Aaltonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aros Applied Biotechnology Aps
Original Assignee
Aros Applied Biotechnology Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aros Applied Biotechnology Aps filed Critical Aros Applied Biotechnology Aps
Publication of DE602004027086D1 publication Critical patent/DE602004027086D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602004027086T 2003-12-27 2004-12-23 Klassifizierung von kolonkrebs Active DE602004027086D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200301940 2003-12-27
DKPA200400096 2004-01-24
DKPA200400586 2004-04-07
DKPA200401843 2004-11-26
PCT/DK2004/000914 WO2005064009A1 (en) 2003-12-27 2004-12-23 Classification of cancer

Publications (1)

Publication Number Publication Date
DE602004027086D1 true DE602004027086D1 (de) 2010-06-17

Family

ID=34743750

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027086T Active DE602004027086D1 (de) 2003-12-27 2004-12-23 Klassifizierung von kolonkrebs

Country Status (6)

Country Link
US (1) US20090297506A1 (de)
EP (1) EP1704248B1 (de)
AT (1) ATE466958T1 (de)
CA (1) CA2592504A1 (de)
DE (1) DE602004027086D1 (de)
WO (1) WO2005064009A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1672079A1 (de) * 2004-12-20 2006-06-21 Georg-August-Universität Göttingen Stiftung öffentlichen Rechts Verfahren für Krebsdiagnose
NZ544432A (en) * 2005-12-23 2009-07-31 Pacific Edge Biotechnology Ltd Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS
US20110236389A1 (en) * 2007-05-22 2011-09-29 Human Antibodomics Development (Sip) Limited Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof
EP2218794A1 (de) * 2009-02-13 2010-08-18 Alphagenics International SA Instabilitätserkennung in Regionen mit genomischem DNA mit einfacher Tandemwiederholung
EP2655661B1 (de) * 2010-12-23 2015-03-11 Agendia N.V. Verfahren und mittel zur molekularen klassifizierung von kolorektalkarzinomen
WO2013113696A1 (en) 2012-01-30 2013-08-08 Vib Vzw Means and method for diagnosis and treatment of alzheimer's disease
EP2700949A1 (de) 2012-08-24 2014-02-26 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Verwendung von Biliverdinreduktaseproteinen als Krebsmarker
SG10201914022QA (en) 2014-11-13 2020-03-30 Univ Johns Hopkins Checkpoint blockade and microsatellite instability

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1361286A1 (de) * 2002-04-18 2003-11-12 MTM Laboratories AG Methode, um Krebs zu detektieren

Also Published As

Publication number Publication date
US20090297506A1 (en) 2009-12-03
ATE466958T1 (de) 2010-05-15
EP1704248B1 (de) 2010-05-05
WO2005064009A9 (en) 2009-11-05
WO2005064009A1 (en) 2005-07-14
CA2592504A1 (en) 2005-07-14
EP1704248A1 (de) 2006-09-27

Similar Documents

Publication Publication Date Title
DE602004027600D1 (de) Genexpressionsmarker für die prognose von brustkrebs
BRPI0513029A (pt) método para produzir uma proteìna de eritropoietina carbamilada, proteìna de eritropoietina carbamilada, composto, composição farmacêutica, métodos de tratamento de uma doença ou condição crÈnica, sub-crÈnica e aguda e de tratamento de uma doença do sistema nervoso central ou sistema nervoso periférico, e, uso de um composto
BR0315689A (pt) Alvo para terapia de dano cognitivo
NO20055741D0 (no) Nye kjemiske forbindelser
ATE492651T1 (de) Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs
ATE515277T1 (de) Zusammensetzungen und verfahren zum beschichten von medizinischen implantaten
DE60329274D1 (de) Kontrastmittel und verfahren zum imaging von naaldase oder psma
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
MXPA04000622A (es) Pirazolilcarboxanilidas como funguicidas.
MXPA05014166A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
WO2004080418A3 (en) Nucleic acid compounds for inhibiting angiogenesis and tumor growth
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
ATE448232T1 (de) Substituierte heterozyklen
DE60332096D1 (de) Mikrosatellitenmarker in form von mononukleotidwiederholungen zur detektion von mikrosatelliteninstabilität
EA200500064A1 (ru) Многофункциональные маркеры продуктов и способы их получения и применения
DE602004027086D1 (de) Klassifizierung von kolonkrebs
ECSP056057A (es) Compuestos de benzo[1,2,5]tiadiazole
NO20054631L (no) Antistoff mot tumorspesifikt antigen som mal
HK1086591A1 (en) Crystalline vap-1 and uses thereof
DE602005015329D1 (de) Rutheniumkomplexe zur krebsbehandlung
EP1642969A4 (de) Fluoreszenzprotein und pigmentprotein
DE10345021A1 (de) Verfahren zur nichtinvasiven Früherkennung von Dickdarmkrebs und/oder Darmkrebsvorläuferzellen
WO2005002414A3 (en) Prognosis determination in ewing sarcoma patients by means of genetic profiling
DE60328621D1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition